Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Pharma Patent Cliff: Why Worst Seems Over
Seeking Alpha
Saturday, March 1, 2014 - 11:56am
tags:
patent cliff, generics
An Update On Acadia Pharmaceuticals
Seeking Alpha
Saturday, March 1, 2014 - 11:54am
tags:
Acadia
Activist Investors Agitating Biotechs Bring Multi-Bagger Returns
Motley Fool
Saturday, March 1, 2014 - 11:53am
tags:
InterMune Stuns Markets, but Is It Overvalued?
Motley Fool
Saturday, March 1, 2014 - 11:51am
tags:
InterMune
Arena Prescription Sales Up: Stops Stock Slide
Seeking Alpha
Saturday, March 1, 2014 - 11:50am
tags:
Arena Pharmaceuticals
3 Stocks Improving Performance Of The Drugs Industry
TheStreet.com
Friday, February 28, 2014 - 12:19pm
tags:
Celgene, Merck, JNJ
Report: Novartis reorganization quietly claims 3,000 jobs in just 4 months
Fierce Biotech
Friday, February 28, 2014 - 12:14pm
tags:
Novartis, layoffs, reorganization
Analysts cheer on Merck's comeback campaign, pumping up blockbuster forecasts
Fierce Biotech
Friday, February 28, 2014 - 12:13pm
tags:
Merck, MK-3475
Endo loss widens, R&D chief departs amid regulatory struggles
Fierce Pharma
Friday, February 28, 2014 - 12:11pm
tags:
Endo Health Solutions, earnings
Questcor continues lower as FDA says reviewing Acthar lab test results
The Fly on the Wall
Friday, February 28, 2014 - 11:58am
tags:
Questcor Pharmaceuticals, FDA, Acthar
Generic-Drug Failures Spur Concern as FDA Steps Up Action
Bloomberg
Friday, February 28, 2014 - 11:56am
tags:
generics, FDA
Small Is Beautiful? Not Without Biotech
Barron's
Friday, February 28, 2014 - 11:54am
tags:
biotech, Intercept Pharma
Merck's NOXAFIL gets positive opinion from CHMP
Yahoo/Fly on the Wall
Friday, February 28, 2014 - 11:50am
tags:
Merck, CHMP, Noxafil, Europe
Ligand says partner GSK submits application for Promacta
Yahoo/Fly on the Wall
Friday, February 28, 2014 - 11:48am
tags:
Ligand Pharmaceuticals, GSK, Promacta
Auxilium Q4 Beats Estimates, But Guidance Cautious
Investors.com
Friday, February 28, 2014 - 11:47am
tags:
earnings, Auxilium
Losses widen, but investors heartened by Clovis drug results
Markewatch
Friday, February 28, 2014 - 11:42am
tags:
Clovis Oncology, earnings, CO-1686
Bluebird Bio May Turn Dreams Into Reality
Seeking Alpha
Friday, February 28, 2014 - 10:33am
tags:
Bluebird Bio, gene therapy
Roche, Discuva enter deal to develop therapies against multi-drug resistant bacteria
First Word Pharma
Friday, February 28, 2014 - 10:30am
tags:
Roche, Discuva, antibiotic resistance, drug discovery, R&D
Illumina DNA Screen for Down Syndrome Found More Accurate
Bloomberg
Friday, February 28, 2014 - 8:44am
tags:
Illumina, Downs Syndrome, diagnostics
GSK trims Witty's bonus in face of China probe
Fierce Pharma
Friday, February 28, 2014 - 8:41am
tags:
China, GSK, Andrew Witty, executive pay

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.